Sign In
Buy VRTX
$441.74
+13.40 (+3.13%)
At Close: Jun 04, 2026
Here's Why Vertex Pharmaceuticals (VRTX) Gained But Lagged the Market Today
07:05pm, Monday, 22'nd Jul 2024
In the most recent trading session, Vertex Pharmaceuticals (VRTX) closed at $495.91, indicating a +0.88% shift from the previous trading day.
3 Gene Editing Stocks Shaping the Future of Medicine
04:45pm, Monday, 22'nd Jul 2024
Gene editing stocks represent one of the biggest investing trends in biopharma in recent years. The gene editing field employs advanced technologies to edit the DNA of different organisms, thereby ope
U.S. M2 money supply has done something that no one has witnessed since the Great Depression. Meanwhile, the benchmark S&P 500 is at one of its priciest valuations in history.
The 3 Best Neuroscience Biotech Stocks to Buy Now
07:00am, Friday, 19'th Jul 2024
Problems with the central nervous system are the second leading cause of death globally, the World Health Organization determined in 2022. One reason for this situation is that it's extremely difficul
3 Gene Editing Stocks That Could Grow Your Wealth
01:30pm, Wednesday, 17'th Jul 2024
Gene editing stocks are often biopharmaceutical companies. At these firms, scientists use technology to change the DNA of organisms such as plants, bacteria and animals.
Add These 5 Hot Biotech Stocks In July
09:22am, Wednesday, 17'th Jul 2024
Investing in biotech stocks can be rewarding. Not just because these stocks have the potential to produce meaningful gains in your portfolio, but also because when you invest in them, you're investing
The Zacks Analyst Blog ASML, SAP, Nvidia, Vertex and EssilorLuxxottica
07:45am, Tuesday, 16'th Jul 2024
ASML, SAP, Nvidia, Vertex and EssilorLuxxottica are included in this Analyst Blog.
Vertex Pharmaceuticals (VRTX) Exceeds Market Returns: Some Facts to Consider
07:06pm, Monday, 15'th Jul 2024
Vertex Pharmaceuticals (VRTX) concluded the recent trading session at $490.85, signifying a +0.43% move from its prior day's close.
Bull Market and Beyond: 2 Stocks Just Waiting to Soar
07:15am, Monday, 15'th Jul 2024
Vertex Pharmaceuticals and Axsome Therapeutics are moving toward key regulatory approvals. Thanks to solid tailwinds, both biotechs should handsomely reward investors over the long run.
Stock-Split Watch: 2 Healthcare Stocks That Look Ready to Split
04:15am, Monday, 15'th Jul 2024
Many top companies have announced stock splits this year after their shares surged in recent times. These operations lower the price of each individual share, making the stock more accessible for a br
Got $1,000? 2 Incredible Growth Stocks to Buy and Hold Forever
09:15am, Sunday, 14'th Jul 2024
These healthcare businesses are booming. Vertex Pharmaceuticals is raking in approvals, cash, and profits.
Why Investors Need to Take Advantage of These 2 Medical Stocks Now
09:50am, Wednesday, 10'th Jul 2024
The Zacks Earnings ESP is a great way to find potential earnings surprises. Why investors should take advantage now.
Vertex: Strategic Diversification From Gene Therapy To Acute Pain Management
12:31pm, Tuesday, 09'th Jul 2024
Vertex's stock has risen 18% since last December, matching the SPY index, bolstered by promising Phase 2 data for VX-548 in diabetic peripheral neuropathy. Vertex is expanding into gene therapies and
3 No-Brainer Stocks to Buy in July
08:00am, Monday, 08'th Jul 2024
Eli Lilly could be headed for a market capitalization above $1 trillion. Regeneron has overcome bumps and shows no signs of slowing down.
3 Pharma Stocks Already Ushering in the Next Biotech Boom
06:00am, Monday, 08'th Jul 2024
Let's get down to it: why should investors consider pharma stocks? Primarily, it comes down to the permanence of the underlying narrative.
